China Universal Asset Management Company’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Sell
2,335
-246
-10% -$24.6K 0.01% 346
2026
Q1
$174K Buy
2,581
+211
+9% +$15.7K 0.01% 363
2025
Q4
$187K Sell
2,370
-169
-7% -$11.5K 0.01% 349
2025
Q3
$85.5K Sell
2,539
-368
-13% -$9.06K 0.01% 401
2025
Q2
$41.5K Buy
2,907
+3
+0.1% +$39 ﹤0.01% 427
2025
Q1
$40.6K Sell
2,904
-165
-5% -$2.24K ﹤0.01% 431
2024
Q4
$47.3K Buy
+3,069
New +$46.7K ﹤0.01% 452

Other funds holding INBX

China Universal Asset Management Company's INBX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Inhibrx (INBX) stake by 9.5% in Q2 2026, selling an estimated $24.6K and leaving 2,335 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #346.

China Universal Asset Management Company first reported a position in INBX in Q4 2024 and has held it in 7 quarters since. 23 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • China Universal Asset Management Company held 2,335 shares of Inhibrx worth $221K as of Q2 2026.
  • China Universal Asset Management Company sold 246 Inhibrx shares in Q2 2026, an estimated $24.6K.
  • Inhibrx made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #346 holding.
  • China Universal Asset Management Company first reported a position in Inhibrx in Q4 2024 and has held it in 7 quarters since.
  • 23 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.